Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

See How to

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
Psychedelic Capital

Psychedelic Capital

Date of beginning

Thursday, 28 January 2021

Duration

1 day

City

Virtual Event

Country

Canada

Contact

Microdose Psychedelic Insights

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Expected participants

500

Memo

Networking at its Finest Build RelationshipsAside from getting access to pre-IPO investment opportunities, our events allow attendees to join in group discussions, chat directly with presenting companies, and speed network 1-on-1 with attendees. It's just like being at a real conference. Raise FundsAs a presenting sponsor, you get to connect directly with some of the earliest moving investors in the psychedelic industry. We'll supply you with a list of interested contacts after the show, and you get to distribute your pitch deck to our entire audience of 2000+ investors. Discover the Agenda*All times are Eastern Standard Timezone. 4:45PM: PSYGEN INDUSTRIESPsygen IndustriesPsygen is a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications. 5:15PM: THE FIRST RAISE - Panel 5:45PM: ALBERT LABSAlbert LabsAlbert Labs is the first psychedelics company pioneering Real World Evidence Studies in hospital settings across the UK and Europe to deliver treatment therapies for urgent, unmet needs.Through a collaboration with leading academic institutions, hospital networks and existing reimbursement mechanisms; Albert Labs empowers scientists, researchers, and medical professionals to accelerate safe patient treatment whilst collecting data to protect and improve its psilocybin based medicines. Starting with cancer-related anxiety, depression and existential crisis, Albert Labs will bring psilocybin-assisted therapy to the UK and Europe before expanding globally. 6:15PM: LIFE IN PUBLIC MARKETS - Panel URL:Tickets: https://go.evvnt.com/728231-1?pid=5569 Price:General Admission: CAD 50.00 Time: 4:30 pm to 7:30 pm